Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 14/20 | 0.41 |
| ▸ | PPARA | Q07869 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | PPARG | P37231 | 1/20 | 0.35 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4025632 | 0.80 | PPARA (0.61) | PPARAMAPTTSHRKDM4ENPC1 | |
| SCHEMBL4031035 | 0.71 | PPARA (0.65) | PPARAMAPTTSHRKDM4ENPC1 | |
| SCHEMBL5915238 | 0.71 | PTGER4 (0.38) | FFAR1PPARAMAPTTSHRKDM4E | |
| SCHEMBL4025495 | 0.70 | PPARA (0.60) | PPARAMAPTKDM4ENPC1ALDH1A1 | |
| SCHEMBL4030636 | 0.69 | FFAR1 (0.53) | FFAR1PPARAMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL4027562 | 0.67 | FFAR1 (0.53) | FFAR1PPARAMAPTPPARG | |
| SCHEMBL4029821 | 0.67 | PPARA (0.65) | PPARAMAPTKDM4ENPC1ALDH1A1 | |
| SCHEMBL4027986 | 0.66 | PPARG (0.64) | PPARAMAPTKDM4ENPC1ALDH1A1 | |
| SCHEMBL4025238 | 0.65 | PPARA (0.69) | FFAR1PPARAPPARG | |
| SCHEMBL4029070 | 0.65 | PPARA (0.63) | PPARAMAPTKDM4ENPC1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060142277-A1 | Substituted aralkyl derivatives | CADILA HEALTHCARE LIMITED | 2006-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060142277-A1 | Substituted aralkyl derivatives | UGT1A7, UGT1A10, UGT2B7 | FFAR1 2147/4885PPARA 2339/4885MAPT 87/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.